» Authors » Simon Anderson

Simon Anderson

Explore the profile of Simon Anderson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 398
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Anderson S, Carter R, Roberts D, Thomas P, Hassan E
Palliat Care Soc Pract . 2025 Feb; 19:26323524251320104. PMID: 39974543
Background: Currently, there are over 70 hospice societies spread across urban, rural, and remote communities in BC. However, these societies are not utilized to their fullest potential, primarily due to...
2.
Maharaj S, Seepersad R, Sooknanan J, Anderson S, Franco D, Ramdass A, et al.
Front Public Health . 2024 Mar; 12:1344387. PMID: 38425469
Widespread crime has become a worldwide problem so much so that violence is now ranked fourth globally in its contribution to disability-adjusted life years in the 10 to 24 age...
3.
Ferguson T, Webster-Kerr K, Tulloch-Reid M, Bennett N, Ho J, Davidson T, et al.
F1000Res . 2024 Jan; 11:721. PMID: 38264475
Background: Excess dietary salt consumption is a major contributor to hypertension and cardiovascular disease. Public education programs on the dangers of high salt intake, and population level interventions to reduce...
4.
Heald A, Stedman M, Daly C, Warner-Levy J, Livingston M, Hussain L, et al.
Cardiovasc Endocrinol Metab . 2023 Jun; 12(3):e0286. PMID: 37361477
Methods: We undertook an anonymised search across one Primary Care Network in Cheshire, UK with a total population of 32 301 individuals. We reviewed the health records of anyone who...
5.
Ball P, Thompson E, Anderson S, Gwenin V, Ashoorzadeh A, Smaill J, et al.
Biosci Rep . 2023 Apr; 43(4). PMID: 37067816
Directed enzyme prodrug therapy is a highly promising anti-cancer strategy. However, the current technology is limited by inefficient prodrug activation and the dose-limiting toxicity associated with the prodrugs being tested;...
6.
Honap S, Anderson S
N Z Med J . 2023 Apr; 136(1573):124-127. PMID: 37054464
Nil.
7.
Bayoumy A, van Liere E, Simsek M, Warner B, Loganayagam A, Sanderson J, et al.
BMC Gastroenterol . 2022 Apr; 22(1):208. PMID: 35473670
No abstract available.
8.
Heald A, Aamir A, Laing I, Anderson S, Livingston M
J Ayub Med Coll Abbottabad . 2022 Feb; 33(4):704-705. PMID: 35124936
No abstract available.
9.
Bayoumy A, Mulder C, Loganayagam A, Sanderson J, Anderson S, Boekema P, et al.
Ther Drug Monit . 2021 Sep; 43(5):617-623. PMID: 34521801
Background: In inflammatory bowel disease (IBD), conventional thiopurine users cease treatment in 60% of cases within 5 years, mostly because of adverse events or nonresponse. In this study, the authors...
10.
Heald A, Laing I, Anderson S, Livingston M
Cardiovasc Endocrinol Metab . 2021 Aug; 10(3):191-192. PMID: 34386722
No abstract available.